Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |